Combined low-pass whole genome and targeted sequencing in liquid biopsies for pediatric solid tumors
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined low-pass whole genome and targeted sequencing in liquid biopsies for pediatric solid tumors
Authors
Keywords
-
Journal
npj Precision Oncology
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-02-20
DOI
10.1038/s41698-023-00357-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma
- (2022) Marco Lodrini et al. CLINICAL CANCER RESEARCH
- Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533
- (2022) Laura M. Madanat-Harjuoja et al. JOURNAL OF CLINICAL ONCOLOGY
- Fusion transcripts as liquid biopsy markers in alveolar rhabdomyosarcoma and synovial sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS)
- (2022) Sabine Stegmaier et al. PEDIATRIC BLOOD & CANCER
- The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies
- (2022) Pablo Berlanga et al. Cancer Discovery
- Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular Diagnostics
- (2022) Marco Lodrini et al. Cancers
- Blood-Derived Liquid Biopsies Using Foundation One® Liquid CDx for Children and Adolescents with High-Risk Malignancies: A Monocentric Experience
- (2022) Fanny Cahn et al. Cancers
- Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma
- (2022) Mrinal M. Gounder et al. Nature Communications
- Fragmentation patterns and personalized sequencing of cell‐free DNA in urine and plasma of glioma patients
- (2021) Florent Mouliere et al. EMBO Molecular Medicine
- A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas
- (2021) Avanthi Tayi Shah et al. MOLECULAR CANCER THERAPEUTICS
- Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study
- (2021) Gui‐Qi Zhu et al. Molecular Oncology
- Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study
- (2021) Jeffrey J. Szymanski et al. PLOS MEDICINE
- Aqueous Humor as a Liquid Biopsy for Retinoblastoma: Clear Corneal Paracentesis and Genomic Analysis
- (2021) Mary E. Kim et al. Jove-Journal of Visualized Experiments
- Comprehensive Somatic Copy Number Analysis Using Aqueous Humor Liquid Biopsy for Retinoblastoma
- (2021) Mary E. Kim et al. Cancers
- Inter-eye genomic heterogeneity in bilateral retinoblastoma via aqueous humor liquid biopsy
- (2021) Elyssa Y. Wong et al. npj Precision Oncology
- Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
- (2021) Anthony P.Y. Liu et al. CANCER CELL
- The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples
- (2021) Ruben Van Paemel et al. EUROPEAN JOURNAL OF CANCER
- Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies
- (2019) Samuel D. Abbou et al. PEDIATRIC BLOOD & CANCER
- The genomic landscape of pediatric cancers: Implications for diagnosis and treatment
- (2019) E. Alejandro Sweet-Cordero et al. SCIENCE
- Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study
- (2019) Morini et al. Cancers
- Progress toward liquid biopsies in pediatric solid tumors
- (2019) Daniel A. Weiser et al. CANCER AND METASTASIS REVIEWS
- Pediatric Solid Tumors of Infancy: An Overview
- (2018) Wendy Allen-Rhoades et al. PEDIATRICS IN REVIEW
- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group
- (2018) David S. Shulman et al. BRITISH JOURNAL OF CANCER
- OncoKids
- (2018) Matthew C. Hiemenz et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Enhanced detection of circulating tumor DNA by fragment size analysis
- (2018) Florent Mouliere et al. Science Translational Medicine
- Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
- (2017) Viktor A. Adalsteinsson et al. Nature Communications
- ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients
- (2015) D. Chu et al. CLINICAL CANCER RESEARCH
- Circulating free DNA as non-invasive diagnostic biomarker for childhood solid tumors
- (2015) Sho Kurihara et al. JOURNAL OF PEDIATRIC SURGERY
- Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord
- (2015) Yuxuan Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Detection of tumorALKstatus in neuroblastoma patients using peripheral blood
- (2015) Valérie Combaret et al. Cancer Medicine
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Integrative genomics viewer
- (2011) James T Robinson et al. NATURE BIOTECHNOLOGY
- Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma
- (2008) Tatsuo Kuroda et al. JOURNAL OF PEDIATRIC SURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started